Uipath is trading now, 4.1% down at $13.44, as investors reassess the September 3 earnings report and softer forward growth outlook.
- Third-quarter guidance implies approximately 8% growth, while coverage cites slower enterprise decision-making and modest net-new ARR.
- Competitive AI risks and concerns that growth reacceleration may take longer are weighing on sentiment.
- Broad risk-off trading adds pressure, with Nasdaq down 0.58% on September 9, 2026.